Arvin Capital Management LP bought a new position in shares of Danaher Co. (NYSE:DHR – Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm bought 31,170 shares of the conglomerate’s stock, valued at approximately $8,666,000. Danaher makes up approximately 2.8% of Arvin Capital Management LP’s investment portfolio, making the stock its 14th biggest position.
Several other institutional investors have also recently added to or reduced their stakes in the company. Fort Pitt Capital Group LLC raised its stake in shares of Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after acquiring an additional 7,421 shares during the last quarter. Good Life Advisors LLC bought a new stake in shares of Danaher during the third quarter worth $217,000. Oak Thistle LLC bought a new position in shares of Danaher in the second quarter valued at about $363,000. Harvest Portfolios Group Inc. lifted its position in Danaher by 1.2% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after buying an additional 2,465 shares in the last quarter. Finally, Diversified Trust Co grew its holdings in Danaher by 75.4% during the 2nd quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock worth $1,090,000 after acquiring an additional 1,874 shares during the last quarter. 79.05% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on DHR. UBS Group decreased their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Stifel Nicolaus upped their price target on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Stephens reiterated an “overweight” rating and issued a $315.00 price objective on shares of Danaher in a research report on Wednesday, October 23rd. Robert W. Baird cut their target price on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Finally, StockNews.com raised shares of Danaher from a “hold” rating to a “buy” rating in a report on Wednesday, November 27th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $287.16.
Danaher Trading Up 0.4 %
NYSE:DHR opened at $239.69 on Monday. The company has a market cap of $173.12 billion, a P/E ratio of 45.74, a price-to-earnings-growth ratio of 4.41 and a beta of 0.85. Danaher Co. has a twelve month low of $215.68 and a twelve month high of $281.70. The business has a 50 day moving average price of $254.59 and a two-hundred day moving average price of $259.41. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the previous year, the business earned $2.02 earnings per share. Danaher’s quarterly revenue was up 3.1% on a year-over-year basis. As a group, analysts expect that Danaher Co. will post 7.5 EPS for the current fiscal year.
Danaher Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.45%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio is 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- What is a buyback in stocks? A comprehensive guide for investors
- Semtech Stock Leads Industrial Semiconductors’ Comeback
- Most active stocks: Dollar volume vs share volume
- Dogs of Tech: 3 Semiconductor Stocks Set for a 2025 Rebound
- Insider Buying Explained: What Investors Need to Know
- 2 Home Improvement Leaders Building Momentum for Upside
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.